Gossamer Announces Resignation of Chief Medical Officer Jakob Dupont

Gossamer Bio’s chief medical officer, Jakob Dupont, is leaving the company this week. Dupont is resigning to “pursue oncology opportunities” closer to his family in the San Francisco Bay Area, the company reported Tuesday.

Dupont’s resignation takes effect Thursday, according to a regulatory filing. Gossamer (NASDAQ: [[ticker:GOSS]]) said he will advise the San Diego-based company on the development of one of the oncology biotech’s clinical-stage assets, investigational pancreatic cancer treatment GB1275, as a consultant through a transitional period. Dupont joined Gossamer in December 2018 from Roche’s Genentech, where he led global development of a number of cancer therapies.

Author: Sarah de Crescenzo

Sarah is Xconomy's San Diego-based editor. Prior to joining the team in 2018, she wrote about startups, tech and finance at the San Diego Business Journal. Her decade of full-time news experience includes coverage of subjects including campaign finance, crime and courts as a reporter and editor at outlets throughout California, including the Orange County Register. She earned a bachelor's degree in English Literature at UC San Diego, where she wrote for the student newspaper and played collegiate lacrosse. In 2019, she earned an MBA at UC Irvine.